SZSisen Zhang

Sisen Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sisen Zhang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Yifan Huang

    The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China

    5 shared publications
  • Xiaopeng Liu

    The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China

    4 shared publications
  • Xiaozhan Yang

    The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China

    4 shared publications
  • Xiaoqing Yang

    The Fifth Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China

    3 shared publications
  • Baojun Zhang

    Department of Pathogenic Microbiology and Immunology, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, Shaanxi, China

    2 shared publications
  • Na Gao

    Translational Medicine Research Center, Zhengzhou People’s Hospital, Zhengzhou, China

    2 shared publications

Latest Publications

  • Open Access

    Active abdominal compression-decompression cardiopulmonary resuscitation versus standard cardiopulmonary resuscitation for adult cardiac arrest: a systematic review and meta-analysis

    by Ruifang Cui, Xiaopeng Liu, Xiaoqing Yang, Yifan Huang, Xiaozhan Yang, Sisen Zhang

    This systematic review and meta-analysis evaluated the clinical efficacy and safety of active abdominal compression-decompression cardiopulmonary resuscitation (AACD-CPR) compared with standard cardiopulmonary resuscitation (STD-CPR) in patients experiencing cardiac arrest (CA). We systematically searched 11 databases from inception to November 2025, including eight randomized controlled trials. Outcomes assessed included return of spontaneous circulation (ROSC), survival, neurological outcomes, hemodynamic parameters, arterial blood gas parameters, oxygen metabolism parameters, and adverse events. Data analysis was performed using RevMan 5.4.1, and certainty of evidence was assessed using the grading of recommendations assessment, development, and evaluation (GRADE) framework. AACD-CPR was associated with a higher return of spontaneous circulation (ROSC) rate and a shorter time to ROSC, whereas 2-week survival did not differ significantly between groups. Several exploratory physiological outcomes showed between-group differences, but substantial heterogeneity was present and many estimates were based on only two or three small studies. Rib fractures were less frequent in two studies, while evidence for other adverse events was limited. The certainty of evidence ranged from very low to moderate. AACD-CPR represents a promising resuscitation approach, but the current evidence remains insufficient to support broader clinical implementation. Larger multicenter randomized trials involving diverse populations are needed to evaluate clinically meaningful outcomes, including survival to hospital discharge, long-term survival, neurologically favorable survival, and procedure-related safety.

  • Open Access

    Active abdominal compression‑decompression cardiopulmonary resuscitation attenuates neuroinflammation associated with TLR4/NF‑κB signaling in a rat model of cardiac arrest

    by Xiaopeng Liu, Xiaoqing Yang, Yifan Huang, Xinyuan Kong, Jiankai Gao, Hongyu Wang, Sisen Zhang

    Cardiac arrest (CA) induces cerebral ischemia‑reperfusion injury, which is a major contributor to mortality and neurological dysfunction following resuscitation. Active abdominal compression‑decompression cardiopulmonary resuscitation (AACD‑CPR) has emerged as a potential alternative to standard cardiopulmonary resuscitation (STD‑CPR). The present study aimed to investigate whether AACD‑CPR attenuates neuroinflammation after CA/CPR and whether this effect is associated with changes in Toll‑like receptor 4/nuclear factor‑κB (TLR4/NF‑κB)‑related signaling. A rat model of CA was established, followed by resuscitation with either STD‑CPR or AACD‑CPR. Return of spontaneous circulation (ROSC), survival, NDS and neuronal injury were evaluated. The expression levels of TLR4, NF‑κB and inflammation‑related markers, including tumor necrosis factor‑α, interleukin‑1 β, glial fibrillary acidic protein (GFAP) and ionized calcium‑binding adapter molecule 1 in brain tissue were assessed by western blotting and immunohistochemistry. Compared with STD‑CPR, AACD‑CPR markedly reduced resuscitation duration and improved early neurological outcomes. Although the ROSC rate and short‑term survival rate were numerically higher in the AACD‑CPR group than in the STD‑CPR group, these differences did not reach statistical significance and therefore should not be interpreted as evidence of a definitive survival benefit. AACD‑CPR was also associated with reduced neuronal injury, decreased expression of proinflammatory cytokines and glial activation markers and downregulation of TLR4/NF‑κB‑related proteins in brain tissue. AACD‑CPR improved early neurological outcomes and attenuated neuroinflammatory responses in this rat model of CA/CPR. These effects were accompanied by suppression of TLR4/NF‑κB‑related signaling. However, as this was a preclinical small‑animal study, the findings should be interpreted cautiously and not as evidence that AACD‑CPR can clinically replace STD‑CPR. Further studies in large‑animal models and well‑designed clinical investigations are required to validate its safety, feasibility and translational relevance.

  • Open Access

    Neuroprotective Mechanisms of Hyperbaric Oxygen Therapy in Cerebral Ischemia-Hypoxia Injury Following Cardiopulmonary Resuscitation

    by Yifan Huang, Xiaopeng Liu, Xiaozhan Yang, Sisen Zhang

    Despite significant advancements in cardiopulmonary resuscitation (CPR) techniques, the global burden of sudden cardiac death remains high, with post-CPR survival rates persistently below 8%. Hypoxic-ischemic brain injury (HIBI) is the predominant cause of mortality, accounting for 68% of fatalities following resuscitation. Hyperbaric oxygen (HBO) therapy, which enhances oxygen dissolution in plasma, has demonstrated efficacy in focal cerebral ischemia conditions such as stroke. However, its potential in addressing global cerebral ischemia following CPR—a condition pathophysiologically distinct due to the absence of a salvageable ischemic penumbra and characterized by pan-cerebral energy failure—remains insufficiently explored. This review synthesizes emerging evidence from both focal and global ischemia models, highlighting the role of HBO in modulating key injury mechanisms common to both conditions, including oxidative stress, neuroinflammation, and ferroptosis. By integrating findings on HBO-induced upregulation of endogenous antioxidants, suppression of pro-inflammatory cytokines, and stabilization of mitochondrial function, we propose a combined therapeutic strategy that incorporates HBO with advanced CPR techniques and adjunctive therapies to mitigate HIBI.

  • Open Access

    Gender disparities in out-of-hospital cardiac arrest: implications for public health and bystander interventions in Zhengzhou

    by Xiaopeng Liu, Xiaoqing Yang, Yifan Huang, Xiaozhan Yang, Hongjiang Zhang, Shaojiang Lv, Xiuzhen Kong, Hongyu Wang, Sisen Zhang

    Background: Out-of-hospital cardiac arrest (OHCA) remains a critical public health crisis in China, with survival rates below 1%, notably lower than those reported in developed nations (10%–12%). Gender disparities have emerged as crucial determinants of OHCA outcomes; however, China-specific evidence remains limited. Methods: We conducted a retrospective cohort study of 3,272 adult non-traumatic OHCA patients treated at the Zhengzhou Emergency Medical Rescue Center between 2017 and 2020. Patient characteristics and interventions were analyzed using multivariable logistic regression to assess their associations with prehospital return of spontaneous circulation (ROSC). Results: Among 3,272 OHCA patients, women accounted for 27.6% ( n = 902), and were significantly older than men (70.1 vs. 61.1 years, p < 0.001). Compared with men, women experienced lower rates of witnessed arrest (51.2% vs. 64.0%, p < 0.001), CPR from bystanders (4.8% vs. 7.3%, p = 0.01), AED use (8.9% vs. 12.4%, p = 0.005), and shockable initial rhythm (6.7% vs. 16.1%, p < 0.001). In addition, women were less likely to experience an OHCA in a public location (13.7% vs. 26.4%, p < 0.001). The female sex remained independently associated with a significantly lower prehospital ROSC rate (OR: 0.26; 95% CI: 0.13–0.53, p < 0.001). Conclusion: Significant gender disparities were identified in prehospital outcomes of OHCA patients in Zhengzhou. Compared with men, women were older and less likely to experience a cardiac arrest in public locations, have the event witnessed, receive cardiopulmonary resuscitation (CPR) from a bystander, present with a shockable rhythm, or require an automated external defibrillator (AED). These factors collectively contributed to substantially lowered prehospital ROSC rates among women. Targeted public health strategies–such as expanding inclusive CPR training, promoting gender-sensitive AED use, enhancing community awareness of female resuscitation, and optimizing emergency medical service protocols–are urgently required to reduce these disparities.


  • [Multi-target mechanism and clinical transformation of hyperbaric oxygen therapy in the treatment of hypoxic-ischemic brain injury after cardiopulmonary resuscitation].

    by Yifan Huang, Xiaozhan Yang, Sisen Zhang

    Cardiopulmonary resuscitation (CPR) is a critical life-saving intervention for patients who have suffered cardiac arrest (CA), which helps the organism of CA patients to rapidly restore respiratory and circulatory functions. However, the survival rate of patients after CPR is extremely low. Globally, sudden cardiac arrest causes over 3 million deaths annually, and the survival rate after CPR is less than 8%. Hypoxic ischemic brain injury (HIBI) is the primary cause of death in 68% of these cases. Hyperbaric oxygen therapy (HBOT) enhances the dissolution of oxygen in plasma, increases the arterial blood oxygen partial pressure in the body, and improves tissue hypoxia. It is widely used in conditions of cerebral ischemia and hypoxia (such as stroke, CA, etc), but its role in HIBI following CPR has not been fully studied. Therefore, this article systematically reviews the multi-target mechanisms of HBOT in the treatment of HIBI, including the inhibition of cell apoptosis and necrosis, improvement of oxidative stress, reduction of neuroinflammation, and enhancement of blood-brain barrier permeability and collateral circulation. It also discusses emerging treatment strategies such as HBOT combined with gut microbiome modulation and active abdominal compression-decompression CPR (AACD-CPR), exploring their potential as new therapeutic targets for HIBI post-CPR, with the aim of identifying more promising clinical translation paths to improve neurological functional prognosis and quality of life after CPR.

  • Open Access

    COX7B Is a New Prognostic Biomarker and Correlates with Tumor Immunity in Esophageal Carcinoma

    by Yinsen Song, Na Gao, Zhenzhen Yang, Sisen Zhang, Tanli Fan, Baojun Zhang

    Esophageal carcinoma (ESCA) refers to the most common type of malignant tumor, which reveals that it occurs often all over the world. ESCA is also correlated with an advanced stage and low survival rates. Thus, the development of new prognostic biomarkers is an absolute necessity. In this study, the aim was to investigate the potential of COX7B as a brand-new predictive biomarker for ESCA patients. COX7B expression in pancancer was examined using TIMER2. The statistical significance of the predictive value of COX7B expression was explored. The relationship between COX7B expression and tumor-infiltrating immune cells in ESCA was analyzed by using ssGSEA. In this study, the result indicated that several types of cancers had an abnormally high amount of COX7B. COX7B expression in samples from patients with ESCA was considerably higher than in nontumor tissues. A more advanced clinical stage may be anticipated from higher COX7B expression. According to the findings of Kaplan-Meier survival curves, patients with low COX7B levels had a more favorable prognosis than those with high COX7B levels. The result of multivariate analysis suggested that COX7B expression was a standalone prognostic factor for the overall survival of ESCA patients. A prognostic nomogram including gender, clinical stage, and COX7B expression was constructed, and TCGA-based calibration plots indicated its excellent predictive performance. An analysis of immune infiltration revealed that COX7B expression has a negative correlation with TFH, Tcm, NK cells, and mast cells. COX7B may serve as an immunotherapy target and as a biomarker for ESCA diagnosis and prognosis.


  • Open Access

    Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer

    by Yinsen Song, Na Gao, Zhenzhen Yang, Sisen Zhang, Tianli Fan, Baojun Zhang

    Gastric cancer (GC) is a highly molecular heterogeneous tumor with unfavorable outcomes. The Notch signaling pathway is an important regulator of immune cell differentiation and has been associated with autoimmune disorders, the development of tumors, and immunomodulation caused by tumors. In this study, by developing a gene signature based on genes relevant to the Notch pathway, we could improve our ability to predict the outcome of patients with GC. From the TCGA database, RNA sequencing data of GC tumors and associated normal tissues were obtained. Microarray data were collected from GEO datasets. The Molecular Signature Database (MSigDB) was accessed in order to retrieve sets of human Notch pathway-related genes (NPRGs). The LASSO analysis performed on the TCGA cohort was used to generate a multigene signature based on prognostic NPRGs. In order to validate the gene signature, the GEO cohort was utilized. Using the CIBERSORT method, we were able to determine the amounts of immune cell infiltration in the GC. In this study, a total of 21 differentially expressed NPRGs were obtained between GC specimens and nontumor specimens. The construction of a prognostic prediction model for patients with GC involved the identification and selection of three different NPRGs. According to the appropriate cutoff value, the patients with GC were divided into two groups: those with a low risk and those with a high risk. The time-dependent ROC curves demonstrated that the new model had satisfactory performance when it came to prognostic prediction. Multivariate assays confirmed that the risk score was an independent marker that may be used to predict the outcome of GC. In addition, the generated nomogram demonstrated a high level of predictive usefulness. Moreover, the scores of immunological infiltration of the majority of immune cells were distinctly different between the two groups, and the low-risk group responded to immunotherapy in a significantly greater degree. According to the results of a functional enrichment study of candidate genes, there are multiple pathways and processes associated with cancer. Taken together, a new gene model associated with the Notch pathway may be utilized for the purpose of predicting the prognosis of GC. One potential method of treatment for GC is to focus on NPRGs.


  • Open Access

    Next-generation sequencing and targeted quantitative real-time polymerase chain reaction for detection of Akebiae Caulis in the traditional Chinese medical formula Longdan Xiegan Wan

    by Yinsen Song, Zhenzhen Yang, Peipei Wang, Ke Song, Sisen Zhang, Tianli Fan

    Background: Akebiae Caulis (Mu Tong) is commonly misused by Aristolochiae Manshuriensis Caulis (Guan Mutong) and Clematidis Armandii Caulis (Chuan Mutong), which are nephrotoxic and carcinogenic. However, in the Pharmacopoeia of the People’s Republic of China (2015 Edition), the method for determining Akebiae Caulis remains undefined. Methods: We used DNA barcode-based next-generation sequencing (NGS) combined with quantitative real-time polymerase chain reaction (qPCR) to detect Akebiae Caulis in Longdan Xiegan Wan (LDXGW) for the first time. Compared with chromatographic studies, NGS enables better evaluation of the ingredient components of traditional Chinese medicine (TCM) preparations. The feasibility of qPCR using species-specific primers to determine the authenticity of species has been validated. In this study, the constituents of Akebiae Caulis in LDXGW from three different manufacturers were scanned by NGS. The independently developed qPCR detection primers of Akebiae Caulis, Aristolochiae Manshuriensis Caulis, and Clematidis Armandii Caulis were specifically used to analyze the LDXGW mentioned above. Results: The results showed that qPCR detected Clematidis Armandii Caulis in all commercial samples. Meanwhile, NGS detected the counterfeit species Clematis peterae (Tie-Xian Lian) in all samples. We found that qPCR shows a difference in detecting Akebiae Caulis, but it was not able to identify the unknown additives and adulterants for the primer pairs of Clematidis Armandii Caulis. Conclusions: Hence, it is sensitive and rapid, qPCR is not suitable for detection alone. The NGS approaches offer important novel insights that complement the qPCR method. The combination of NGS and qPCR will be a powerful complement to traditional identification methods of TCM substances.